Rick Collins and Jay Manfre Address Category of Nootropics in NutraIngredients-USA Article
201805.18
0
0

Rick Collins and Jay Manfre Address Category of Nootropics in NutraIngredients-USA Article

Nootropics, often referred to as “smart drugs,” is a hot topic in the dietary supplement industry – with this category of ingredients sometimes considered to be in a gray area between drugs and dietary ingredients. With nootropics continuing to be a complex area of the law, NutraIngredients-USA — the online news service focusing on US…

Important News Surrounding Food And Dietary Supplement Labeling
201805.08
Off
0

Important News Surrounding Food And Dietary Supplement Labeling

– FDA Announces Approximate 1.5-Year Extension of Compliance Dates for Updated Nutrition Information on Food Labels, Including Dietary Supplements – The FDA has announced an important extension surrounding labeling of foods, single serving foods, functional foods and dietary supplements. Noting that “after careful consideration FDA has determined that additional time would help ensure that all…

Rick Collins to Speak on Legal and Regulatory Issues in the Sports Nutrition Industry at Upcoming Webinar
201803.13
Off
0

Rick Collins to Speak on Legal and Regulatory Issues in the Sports Nutrition Industry at Upcoming Webinar

March 14th Webinar Presented by the Council for Responsible Nutrition and Natural Products Insider to Address Key Legislative Issues Facing Supplement Companies Today Rick Collins will be joining with a panel of industry experts to address some of today’s most critical legal and regulatory issues in the sports nutrition arena at an upcoming webinar being…

Rick Collins Featured in Two Natural Products Insider Articles
201712.11
Off
0

Rick Collins Featured in Two Natural Products Insider Articles

Rick Provides Critical Information for Supplement Companies in Bylined Article ““Launching a New Dietary Supplement Product”; Offers Insight on Two Recent Studies Rick Collins is featured in two recent articles in Natural Products Insider, providing important information for supplement companies on the issues and latest regulations affecting the industry today. The articles offer insight into…

Alan Feldstein to Present During Upcoming AHPA Webinar
201711.28
Off
0

Alan Feldstein to Present During Upcoming AHPA Webinar

Session will Address Emerging CGMP Compliance Issues Alan Feldstein, Esq., of Counsel to CGMB and an integral part of the firm’s growing dietary supplements division, will be a featured presenter at an upcoming live webinar hosted by the American Herbal Products Association (AHPA). The AHPA Webinar — “FDA Inspection Trends, cGMP Compliance Issues and Responding…

CGMB Associate David Torreblanca’s Article Published by Natural Products Insider
201612.22
Off
0

CGMB Associate David Torreblanca’s Article Published by Natural Products Insider

Torreblanca Addresses GNC Agreement with Department of Justice Surrounding the Sale of Allegedly Misbranded and Adulterated Dietary Supplements David Torreblanca, an associate at Collins Gann McCloskey & Barry concentrating in the areas of cosmetics, food, and dietary supplement law, has been published by Natural Products Insider addressing the timely topic of GNC’s recent agreement with…

201608.11
Off
0

FDA Releases New Draft NDI Guidance; FDA Warns for Trade-Show Literature; President Signs GMO-Labeling Bill

The latest top stories for the sports nutrition / dietary supplement industry: FDA Releases New Draft New Dietary Ingredient Notification Guidance Today, FDA announced the release of its new, draft New Dietary Ingredient (“NDI”) guidance document, which replaces its previous, July 2011 draft. Please stay tuned for updates as we digest this lengthy new guidance….

201608.10
Off
0

Consumer Reports Study On Dietary Supplements: Industry Responds to Flawed Study and Sensationalism Regarding Supplement Industry

As the September issue of Consumer Reports hits newsstands, consumers across the country will likely be drawn to the magazine’s alarmist cover story on supplements. However, the cover story appears to not only be the result of a seriously flawed study and sensationalistic reporting, but is being viewed by many in the industry as simply…